Novartis Entities Dismissed from 3 Tavist-D Lawsuits in PPA MDL



DOCUMENTS
  • <i>Bonventre</i> Proposed Order
  • <i>Dobson</i> Amended Complaint
  • <i>Dobson</i> Proposed Order
  • <i>Harper</i> Proposed Order


SEATTLE - Two Novartis entities were recently dismissed with prejudice from three lawsuits claiming injuries from the cold medication Tavist-D®. In re Phenylpropanolamine (PPA) Products Liability Litigation. MDL No. 1407 (W.D. Wash.).

Novartis AG and Novartis Corp. agreed to the dismissals 'without admitting or denying any issue....' District Judge Barbara J. Rothstein said the parties stipulated that Novartis Consumer Health has 45 days to file its response to the complaints if it hasn't already done so.

George and Margaret Dobson sued Novartis AG, Novartis Corp. and Novartis Consumer Health Inc. in the Circuit Court for Florida's 7th Judicial District …






UPCOMING CONFERENCES




HarrisMartin's MDL Conference

December 04, 2024 - New York, NY
Virgin Hotels NYC

MORE DETAILS



HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

January 10, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS